Related Experiment Video
Updated: Jul 11, 2026
08:49
Models of Bone Metastasis
Published on: September 4, 2012
Models of carcinogenesis as an escape from mitotic inhibitors
Science (New York, N.Y.)
|May 7, 1976
Abstract:
Diffusible mitotic inhibitors are assumed to govern proliferation of normal cells. Cancer cells may escape regulation by failing to either recognize or secrete inhibitors. In the latter case, probabilities and expected times for reaching a critical clone size are given. Patterns of proliferation will depend on whether the inhibitor concentration is locally or systemically determined.
Insights
Normal cells regulate proliferation using diffusible mitotic inhibitors. Cancer cells may evade this control by not secreting these inhibitors, potentially leading to uncontrolled tumor growth.
Area of Science:
- Cell biology
- Cancer research
- Mathematical modeling
Background:
- Normal cell proliferation is regulated by diffusible mitotic inhibitors.
- Cancer cells may bypass this regulation through impaired inhibitor recognition or secretion.
- Understanding these escape mechanisms is crucial for cancer therapy.
Purpose of the Study:
- To investigate the consequences of cancer cells failing to secrete mitotic inhibitors.
- To model the probabilities and timeframes for tumor clone expansion.
- To explore how local versus systemic inhibitor concentration affects proliferation patterns.
Main Methods:
- Mathematical modeling of cell proliferation dynamics.
- Analysis of inhibitor secretion and recognition failures.
- Stochastic modeling of clone size evolution.
Main Results:
- Formulas are derived for probabilities and expected times to reach critical clone sizes when inhibitors are not secreted.
- Proliferation patterns are shown to be dependent on inhibitor concentration determination (local vs. systemic).
Conclusions:
- Failure to secrete mitotic inhibitors is a viable mechanism for cancer cells to escape growth regulation.
- The spatial distribution of inhibitor concentration significantly influences tumor growth dynamics.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:12What is Cancer?
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...